Article

COPD patients prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils?

2021-01-19

Abstract excerpt

<title>Abstract</title> <p>Background and objective<underline>:</underline> Inhaled corticosteroid (ICS) therapy for COPD should be guided by exacerbations and blood-eosinophils according to the GOLD 2020 strategy document. In the present study, we applied these recent recommendations in a large cohort of COPD patients recruited from general practice. <h4>Methods:</h4> The participating general practitioners (n =...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5bb08590-0f0c-5ff5-bea3-e19777940b19
DOI: 10.21203/rs.3.rs-51349/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COPD patients prescribed inhaled corticosteroid in primary care – Time for re-assessment based on exacerbation rate and blood eosinophils?DOI 10.21203/rs.3.rs-51349/v3Read

Risk Factors for Recurrent Exacerbations in the General Practitioners Based Swiss Chronic Obstructive Pulmonary Disease (COPD) CohortSemantic proximity Read

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.Semantic proximity Read

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1.Semantic proximity Read

Studying the role of elevated eosinophils in warning of an acute attack of chronic obstructive pulmonary diseaseSemantic proximity Read

Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.Semantic proximity Read

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach.Semantic proximity Read

Analysis of the total serum levels of IgE levels in patients with acute exacerbations chronic obstructive pulmonary diseaseSemantic proximity Read

Exacerbations and Lung Function in Polish Patients with Chronic Obstructive Pulmonary Disease Treated with ICS/LABA: 2-Year Prospective, Observational StudySemantic proximity Read

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD – Study protocol for a randomized, double-blind, non-inferiority study (The “RECUT”-Trial)Semantic proximity Read

Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand.Semantic proximity Read

Study of Blood Eosinophils and Plasma Periostin as Biomarkers for Response of COPD Patients to ICS/LABA TreatmentSemantic proximity Read

The Acute COPD Exacerbation Prediction Tool (ACCEPT): development and external validation study of a personalised prediction modelSemantic proximity Read